Abernethy J, Banks J. Account of two instances of uncommon formation, in the viscera of the human body. Philos Trans R Soc Lond. 1793;83:59–66.
Murray CP, Yoo S-J, Babyn PS. Congenital extrahepatic portosystemic shunts. Pediatr Radiol. 2003;33:614–20.
De Gaetano AM, Gui B, Macis G, et al. Congenital absence of the portal vein associated with focal nodular hyperplasia in the liver in an adult woman: imaging and review of the literature. Abdom Imaging. 2004;29:455–9.
Kobayashi N, Niwa T, Kirikoshi H, et al. Clinical classification of congenital extrahepatic portosystemic shunts. Hepatol Res. 2010;40:585–93.
Benedict M, Rodriguez-Davalos M, Emre S, et al. Congenital extrahepatic portosystemic shunt (Abernethy malformation type Ib) with associated hepatocellular carcinoma: case report and literature review. Pediatr Dev Pathol. 2017;20:354–62.
Happaerts S, Foucault A, Billiard JS, et al. Combined hepatocellular-cholangiocarcinoma in a patient with Abernethy malformation and tetralogy of Fallot: a case report. Hepatology. 2016;64(5):1800–2.
Tacyildiz N, Ozdemir EG, Gordu Z, et al. Hepatocellular carcinoma with congenital absence of the portal vein in a child. J Clin Case Rep. 2015;504:2.
Sharma R, Suddle A, Quaglia A, et al. Congenital extrahepatic portosystemic shunt complicated by the development of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2015;14:552–7.
Gordon-Burroughs S, Balogh J, Weiner MA, et al. Liver transplantation in an adult with adenomatosis and congenital absence of the portal vein: a case report. Transpl Proc. 2014;46:2418–21.
Scheuermann U, Foltys D, Otto G. Focal nodular hyperplasia proceeds hepatocellular carcinoma in an adult with congenital absence of the portal vein. Transpl Int. 2012;25:e67–8.
Lisovsky M, Konstas AA, Misdraji J. Congenital extrahepatic portosystemic shunts (Abernethy malformation): a histopathologic evaluation. Am J Surg Pathol. 2011;35:1381–90.
Morotti RA, Killackey M, Shneider BL, et al. Hepatocellular carcinoma and congenital absence of the portal vein in a child receiving growth hormone therapy for turner syndrome. Semin Liver Dis. 2007;27:427–31.
Pichon N, Maisonnette F, Pichon-Lefièvre F, et al. Hepatocarcinoma with congenital agenesis of the portal vein. Jpn J Clin Oncol. 2003;33:314–6.
Lundstedt C, Lindell G, Tranberg KG, et al. Congenital absence of the intrahepatic portion of the portal vein in an adult male resected for hepatocellular carcinoma. Eur Radiol. 2001;11:2228–31.
Taïeb J, Castera L, Boige V, et al. Hepatocellular carcinoma complicating agenesis of the portal vein. Gastroentérol Clin Biol. 1998;22:246.
Joyce AD, Howard ER. Rare congenital anomaly of the portal vein. Br J Surg. 1988;75:1038–9.
Hu GH, Shen LG, Yang J, et al. Insight into congenital absence of the portal vein: is it rare? World J Gastroenterol. 2008;14(39):5969–79.
Iñarrairaegui M, Pardo F, Bilbao JI, et al. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol. 2012;38:594–601.